The past few episodes of the NEXT NORMAL have focused on the SECOND WAVE of the COVID pandemic – likely to hit us in the next 4 of 5 months.
While there’s still a lot we don’t know about this strain of the coronavirus, we have learned a lot since it was detected in December of last year.
Much of that knowledge has come from an historic and piercing international scientific focus on COVID-19. There are hundreds of efforts underway to develop a vaccine and we know that some are well on their way towards human trials.
But there has also been a great deal of research being done on pharmaceutical treatments that don’t immunize us but could help mitigate and minimize the symptoms and effects of COVID-19.
A Halifax-based firm is doing just that. Appili Therapeutics is an infectious disease company that tests drugs currently in use to fight other diseases to see if they have any effect on COVID-19.
It sounds like they’ve found one.
Dr. Armand Balboni is the CEO of Appili Therapeutics. He says they are moving into phase two of trials to evaluate the drug called favipiravir as a preventative treatment against the coronavirus. And they are targeting a very specific – at risk demographic.
Economies are in various stages of reopening across the country. But we do so with one eye on the SECOND WAVE which is expected to hit in the late autumn and last into the winter of 2021.
Are we ready for it. We’ve been asking that question of late from a number of perspectives. In this episode, we look at some of the science lessons and medical lessons we’ve learned during the course of the pandemic so far.
We talk to Dr. Mitch Shulman, and emergency medicine specialist in Montreal and the medical correspondent for iHeart Radio Canada, and our iHeart Radio Canada Science correspondent Professor Dan Riskin to get some clarity on whether we're seeing the start of the second wave already.
We often talk about the heroes of the pandemic and that brings our front line healthcare workers to mind almost immediately. What does the Next Normal look like for them as we approach the possibility of a second wave of COVID-19?
What the learnings they have had as they've faced down the COVID crisis?
Tim Guest is President of the Canadian Nurses Association.